0.0060
+0.0010
+(20.00%)
At close: 2:11:45 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-1,523.3010
-1,523.3010
-1,986.2910
-2,042.2040
-1,461.5230
Investing Cash Flow
-277.4400
-277.4400
--
39.4990
105.8590
Financing Cash Flow
522.9960
522.9960
1,850.2420
4,686.0600
-44.5370
End Cash Position
808.4130
808.4130
4,111.0740
4,238.8570
1,568.9280
Capital Expenditure
--
--
--
-3.8030
--
Issuance of Capital Stock
572.2560
572.2560
2,149.3090
2,856.7520
--
Issuance of Debt
--
--
--
2,289.5130
--
Free Cash Flow
-1,523.3010
-1,523.3010
-1,986.2910
-2,046.0070
-1,461.5230
6/30/2021 - 8/31/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
ATX.AX Amplia Therapeutics Limited
0.0520
-1.89%
CMB.AX Cambium Bio Limited
0.3000
+7.14%